Home›Search›Exploration of Targeted Anti-tumor Therapy

Exploration of Targeted Anti-tumor Therapy

Open Exploration Publishing Inc · China · Est. 1980

ISSN2692-3114
SJR Q2✓ Scopus / SJR✓ DOAJ✓ Open Access
78
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
◆ Scopus Q266
✓ Corroboration (2 more)+12
Total78
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
124
days submission → published
measured · last 12 articles · accept 101d
13
weeks to publish · journal-reported
Average · vs ~15 wk median
Q2
SJR Rank
Top 50% in field
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗
SJR Scorei
0.883
H-Indexi
24
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIPi
0.418
Total Worksi
372
Total Citationsi
3,320
2yr Mean Citednessi
4.57
Open Impact Factor alternative

Aims & Scope

Exploration of Targeted Anti-tumor Therapy aims to publish high-quality research articles, reviews, and perspectives on targeted anti-tumor therapies. The journal covers a broad range of topics including molecular mechanisms of cancer, drug discovery and development, precision oncology, biomarkers, and clinical trials. It also welcomes submissions on emerging areas such as cancer immunotherapy, liquid biopsy, and artificial intelligence in cancer care.

General Information

Country / RegionChina
Primary LanguageEnglish
1st Year Published1980
FrequencyMonthly
StatusActive (last: 2026)
Total Publications372
OA Since2019
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~13 weeks
Acceptance Rate33%
OA LicenseCC BY
OA Rate—

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes
📦 Long-term Preservation
Portico

Think.Check.Submit Compliance

10/12 · 83%
✅
Do you know the journal / publisher?
Open Exploration Publishing Inc
✅
Does the journal have a website?
✓ Linked
✅
Is the ISSN verified?
2692-3114
✅
Indexed in a trusted database?
Scopus, DOAJ, PubMed
✅
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
✅
Not on predatory/blacklists?
✓ Clean
✅
Long-term digital preservation?
Portico
✅
Plagiarism detection in place?
Yes
✅
Listed in DOAJ (verified OA)?
DOAJ verified
✅
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
1
0
2013
30
923
2020
40
378
2021
50
676
2022
83
801
2023
85
575
2024
71
376
2025
21
1
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ2
Cancer ResearchQ3

Subject Classification

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsCancer Cells and MetastasisLung Cancer Research StudiesImmunotherapy and Immune ResponsesHER2/EGFR in Cancer ResearchImmune cells in cancerProtein Degradation and InhibitorsPancreatic and Hepatic Oncology Research

Frequently asked questions about Exploration of Targeted Anti-tumor Therapy

Is Exploration of Targeted Anti-tumor Therapy a predatory journal?

PubScope has no integrity flags on record for Exploration of Targeted Anti-tumor Therapy: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 78/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Exploration of Targeted Anti-tumor Therapy?

Exploration of Targeted Anti-tumor Therapy is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.883.

Is Exploration of Targeted Anti-tumor Therapy indexed in Scopus and Web of Science?

Exploration of Targeted Anti-tumor Therapy is indexed in Scopus, DOAJ.

What is the aims and scope of Exploration of Targeted Anti-tumor Therapy?

Exploration of Targeted Anti-tumor Therapy aims to publish high-quality research articles, reviews, and perspectives on targeted anti-tumor therapies. The journal covers a broad range of topics including molecular mechanisms of cancer, drug discovery and development, precision oncology, biomarkers, and clinical trials. It also welcomes submissions on emerging areas such as cancer immunotherapy, liquid biopsy, and artificial intelligence in cancer care.

What is the acceptance rate of Exploration of Targeted Anti-tumor Therapy?

Exploration of Targeted Anti-tumor Therapy lists a self-reported acceptance rate of approximately 33%. Journal-reported figures can be optimistic — treat it as a rough guide, not a guarantee.

You May Also Like

See all →
Cancer Innovation
John Wiley and Sons Inc
SJR Q1OA
Cancer Treatment and Research Communications
Elsevier Ltd
SJR Q2OA
Oncology Reviews
Frontiers Media SA
SJR Q2OA
European Medical Journal Oncology
European Medical Journal
OA
Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref